eduardo villablanca

group leader

The breakdown of intestinal immune homeostasis may lead to diseases such as IBD, a currently incurable disorder that affects millions of individuals worldwide. The large numbers of patients that fail to respond to available therapies and the high cost of biologic agents highlight an urgent need for alternative treatments, such as those that prevent the disease or promote intestinal regeneration upon injury. My lab exploits competencies in experimental immunology, the versatility of zebrafish models, ex vivo intestinal organoid co-cultures, transcriptomics (bulk, single-cell and spatial level), and translational research to identify mechanisms that modulate the initiation and resolution of IBD.